ChemoTech signs agreement with distributor in south of India
After 100 days of working on the Indian Oncology market, the new team at Scandinavian Meditech Private Limited is pleased to announce a distributor agreement with LifeLinx Surgimed Private Limited, Chennai, in the state of Tamil Nadu. This agreement includes an order of one demo-unit of IQWave™ that will bring revenue of EUR 17,000 to Scandinavian Meditech Private Limited.
LifeLinx, with a total of 15 employees, has a 15-year-old history in the surgical disposables market it South India with a synergistic portfolio of Special Biopsy Products and Wound Care Products for the Oncology Segment.
The ChemoTech sales team in India, under the able leadership of Mehul Chheda, has been working hard on development of local distribution partnerships. Under this agreement, LifeLinx Surgimed Private Limited will soon acquire it's first demo unit for promoting and supporting the D-EECT practice in this territory.
When LifeLinx Surgimed Private Limited have showed a successful launch of IQWave™ in Tamil Nadu some of the neighboring states will also be up for discussion.
For more information, please contact:
Mohan Frick, CEO
Tel: +46 (0)10-218 93 03
This information is such information which Scandinavian ChemoTech AB (publ) are obligated to make public according to EU’s market abuse regulation and the law of securities market. The information was submitted by the agency of above stated contact person, to be made public on Tuesday April 3rd 2018 at 15.30 (CET).
Scandinavian ChemoTech AB (publ)
ChemoTech is a young and dynamic life science company that possesses a great medical expertise and technical knowledge. Our latest launch of IQWave™ is an innovation within electrochemotherapy, that is adapted for the treatment of different types of tumors. ChemoTech strives to contribute to a more accessible cancer care. ChemoTech's shares (CMOTEC B) are listed on NASDAQ First North in Stockholm and Västra Hamnen Corporate Finance AB is the company's Certified Adviser. The company is headquartered in Malmö, in the midst of the medical technology expansionary Öresund region.